Westpac Banking Corp Dexcom Inc Transaction History

Westpac Banking Corp

$1.49 Trillion
Q3 2024

A detailed history of Westpac Banking Corp transactions in Dexcom Inc stock. As of the latest transaction made, Westpac Banking Corp holds 4,190 shares of DXCM stock, worth $325,982. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,190

Previous 3,515 19.2%

Holding current value

$325,982

Previous $399 Million 29.52%

% of portfolio

0.02%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$64.0 - $116.06 $43,200 - $78,340	675 Added 19.2%	4,190 $281 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $375,274 - $477,810	3,402 Added 3010.62%	3,515 $399 Million
Q2 2024 Aug 12, 2024	SELL	$110.31 - $140.45 $375,274 - $477,810	-3,402 Reduced 96.79%	113 $399 Million
Q1 2024 May 09, 2024	SELL	$114.22 - $140.1 $1.75 Million - $2.14 Million	-15,310 Reduced 81.33%	3,515 $488 Million
Q4 2023 Feb 08, 2024	BUY	$75.49 - $124.16 $1.19 Million - $1.96 Million	15,803 Added 522.93%	18,825 $2.34 Billion
Q3 2023 Nov 09, 2023	SELL	$86.06 - $137.93 $451,642 - $723,856	-5,248 Reduced 63.46%	3,022 $282 Million
Q2 2023 Aug 10, 2023	SELL	$112.47 - $130.98 $4.18 Million - $4.87 Million	-37,204 Reduced 81.81%	8,270 $1.06 Billion
Q1 2023 May 03, 2023	SELL	$104.0 - $122.92 $702,728 - $830,570	-6,757 Reduced 12.94%	45,474 $5.28 Billion
Q4 2022 Feb 06, 2023	BUY	$84.98 - $122.67 $1.74 Million - $2.51 Million	20,459 Added 64.39%	52,231 $5.91 Billion
Q2 2022 Aug 10, 2022	BUY	$67.99 - $132.89 $1.62 Million - $3.18 Million	23,894 Added 303.3%	31,772 $2.37 Billion
Q1 2022 May 11, 2022	SELL	$94.08 - $130.2 $4,139 - $5,728	-44 Reduced 0.56%	7,878 $1.01 Million
Q4 2021 Feb 08, 2022	BUY	$129.87 - $162.82 $55,454 - $69,524	427 Added 5.7%	7,922 $4.25 Billion
Q1 2021 May 13, 2021	SELL	$84.79 - $104.74 $893,517 - $1.1 Million	-10,538 Reduced 58.44%	7,495 $673,000
Q4 2020 Feb 11, 2021	SELL	$78.0 - $104.5 $39,000 - $52,250	-500 Reduced 2.7%	18,033 $1.67 Million
Q3 2020 Nov 10, 2020	SELL	$95.51 - $112.95 $825,015 - $975,662	-8,638 Reduced 31.79%	18,533 $1.91 Million
Q2 2020 Aug 12, 2020	SELL	$62.68 - $105.34 $2.59 Million - $4.34 Million	-41,247 Reduced 60.29%	27,171 $2.75 Million
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $897,161 - $1.42 Million	18,773 Added 37.81%	68,418 $4.61 Million
Q4 2019 Feb 11, 2020	BUY	$36.62 - $57.29 $325,918 - $509,881	8,900 Added 21.84%	49,645 $2.72 Million
Q3 2019 Nov 13, 2019	SELL	$35.53 - $43.8 $522,291 - $643,860	-14,700 Reduced 26.51%	40,745 $1.52 Million
Q2 2019 Aug 01, 2019	BUY	$27.84 - $38.92 $282,576 - $395,038	10,150 Added 22.41%	55,445 $0
Q1 2019 May 14, 2019	SELL	$28.07 - $38.18 $130,525 - $177,537	-4,650 Reduced 9.31%	45,295 $0
Q4 2018 Feb 07, 2019	BUY	$26.99 - $37.37 $215,785 - $298,773	7,995 Added 19.06%	49,945 $1.5 Million
Q3 2018 Nov 13, 2018	BUY	$23.35 - $36.72 $979,532 - $1.54 Million	41,950 New	41,950 $0
Q4 2017 Jan 18, 2018	SELL	$11.12 - $15.38 $85,112 - $117,718	-7,654 Closed	0 $0
Q3 2017 Oct 30, 2017	BUY	$11.36 - $18.98 $86,949 - $145,272	7,654	7,654 $0

Others Institutions Holding DXCM

# of Institutions

1,015

Shares Held

352M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Westpac Banking Corp with notifications on news.

Account

Westpac Banking Corp Dexcom Inc Transaction History